Idenix Pharmaceuticals (IDIX +16.6%) moves up today after being initiated with a Buy at Deutsche...

|About: Idenix Pharmaceuticals, Inc. (IDIX)|By:, SA News Editor

Idenix Pharmaceuticals (IDIX +16.6%) moves up today after being initiated with a Buy at Deutsche Bank. The firm says the Street is undervaluing IDIX's new drug pipeline, as investors have been spooked since the FDA put a clinical trials of its lead hepatitis C candidate on hold in August. IDIX recently said study data showed the drug is safe and cured 82% of patients, and the agency's decision on lifting the hold - expected early 2013 - is the key event for the stock.